Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

REDDY-DASATINIB DIN 02514737

Status: Marketed
Holder: DR REDDY'S LABORATORIES LTD
Molecule: DASATINIB (DASATINIB (S)-PROPYLENE GLYCOL)

Health Canada record

Active ingredient(s)DASATINIB (DASATINIB (S)-PROPYLENE GLYCOL) 20 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01EA02 DASATINIB
Original market date16-Sep-2021
Current status date16-Sep-2021
SourceHealth Canada DPD

Establishment licence of the holder

Dr Reddy's Laboratories (UK) Limited — licence , not currently licensed, last inspection rating C (2019-02-12).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DASATINIB (DASATINIB (S)-PROPYLENE GLYCOL)

DINProductCompanyFormStrengthStatus
02514745REDDY-DASATINIBDR REDDY'S LABORATORIES LTDTabletDASATINIB (DASATINIB (S)-PROPYLENE GLYCOL) 50 MGMarketed
02514753REDDY-DASATINIBDR REDDY'S LABORATORIES LTDTabletDASATINIB (DASATINIB (S)-PROPYLENE GLYCOL) 70 MGMarketed
02514761REDDY-DASATINIBDR REDDY'S LABORATORIES LTDTabletDASATINIB (DASATINIB (S)-PROPYLENE GLYCOL) 80 MGMarketed
02514788REDDY-DASATINIBDR REDDY'S LABORATORIES LTDTabletDASATINIB (DASATINIB (S)-PROPYLENE GLYCOL) 100 MGMarketed
02514796REDDY-DASATINIBDR REDDY'S LABORATORIES LTDTabletDASATINIB (DASATINIB (S)-PROPYLENE GLYCOL) 140 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
256142021-04-09Abbreviated New Drug Submission (ANDS)
Request a quote for REDDY-DASATINIB

How to read a Canadian DIN record